483 Round Up: Design Validations, Other Issues Noted at Four Companies

The GMP Letter
A A
FDA inspectors found a DT Medtech facility in Towson, Md., lacked adequate design validation procedures.

To View This Article:

Login

Subscribe To The GMP Letter